1. Home
  2. ASUR vs ELTX Comparison

ASUR vs ELTX Comparison

Compare ASUR & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Asure Software Inc

ASUR

Asure Software Inc

HOLD

Current Price

$8.79

Market Cap

224.4M

Sector

Technology

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$14.85

Market Cap

185.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASUR
ELTX
Founded
1985
2011
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
224.4M
185.4M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
ASUR
ELTX
Price
$8.79
$14.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$14.33
$18.00
AVG Volume (30 Days)
83.9K
126.0K
Earning Date
04-30-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.29
EPS
0.02
N/A
Revenue
$88,952,000.00
$2,301,000.00
Revenue This Year
$16.33
N/A
Revenue Next Year
$9.20
N/A
P/E Ratio
$433.50
N/A
Revenue Growth
63.39
N/A
52 Week Low
$6.80
$7.37
52 Week High
$11.47
$16.00

Technical Indicators

Market Signals
Indicator
ASUR
ELTX
Relative Strength Index (RSI) 47.61 67.60
Support Level $7.91 $9.76
Resistance Level $8.91 N/A
Average True Range (ATR) 0.38 1.30
MACD -0.03 0.35
Stochastic Oscillator 17.36 79.67

Price Performance

Historical Comparison
ASUR
ELTX

About ASUR Asure Software Inc

Asure Software Inc is a provider of cloud-based Human Capital Management (HCM) software solutions delivered as Software-as-a-Service (SaaS) to businesses of all sizes. It facilitates small and mid-sized businesses (SMBs) to develop their Human Capital to get to the next level, stay compliant, and allocate their time, money, and technology toward growth. The company's HCM suite, named AsureHCM, includes cloud-based Payroll and Tax, HR, a Time and Attendance software. Its HR services range from HR projects to outsourcing payroll to HR consulting services. The firm sells its products majorly in the United States.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: